BIOCHEMICAL SOCIETY TRANSACTIONS unlabelled glucose 1-phosphate was added and changes in the concentration of glucose 1-phosphate and glucose 1-[32P]-phosphate activity were followed as the system relaxed back towards equilibrium. The results from a number of such experiments at low concentrations of glucose monophosphates are shown in Fig. 1 . With 32P-labelled substrates, co-transport of glucose I-[32P1phosphate into glucose 6-phosphate was observed. The activity of glucose l-[32P]phosphate fell to 37% of its original value and then returned to that value as chemical equilibrium was reached. Any fall in 32P radioactivity in the I-position of glucose 1,6-biphosphate would not affect this value significantly. The fall in glucose l-[32Plphosphate radioactivity is very similar to that expected for a phosphoenzyme mechanism (see line 3, Fig. 1) .
In similar experiments with 14C-labelled substrates no induced transport was observed (line 1, Fig. 1) . Taken together these results support mechanism 1 and exclude mechanisms 2 and 3. However, mechanism 3 could give rise to the observed induced-transport pattern if the isomerization of the enzymeglucose 1,6-biphosphate complex is rate-limiting as the degree of co-transport for 14C-and 32P-labelled substrates is decreased towards that of mechanism 1. This possibility has been excluded, for to decrease the '*C-co-transport to less than that indicated by line 4 in Fig. 1 , the K , for glucose 1-phosphate would need to be five times less than the experimental value (see Britton & Clarke, 1968) .
Similarly any isomerization of the phosphoenzyme (mechanism 1) should decrease the extent of 3zP-co-transport and lead to 14C-counter-transport especially at high substrate concentrations. No 14C-counter-transport was observed, and under these conditions, experiments indicated that the rate constants for any isomerization must be in excess of 2.7 x Thus these results are only compatible with mechanism 1 or 1'.
To determine the nature of the phosphoenzyme, 10 units of enzyme were incubated for 1 min at 3OoC with 0.25 pCi each of 32P-and "C-labelled glucose 1,6-biphosphate in 1 6 0 m~-histidine/40m~-tris/5 mM-MgCI,, pH 7.4. In the same buffer at 4OC, the mixture was passed down a Sephadex G-25 column. No radioactivity was associated with the enzyme fraction, which suggests that the phosphoenzyme is unstable (probable half-life <6min at 4OC). In contrast the phosphoenzyme from muscle is stable. Gel electrophoresis by the method of Laemmli & Favre (1973) showed that the isoenzyme patterns of the rabbit muscle and liver enzymes are different. It is therefore possible that the apparent bisphosphatase activity associated with the liver enzyme is of metabolic importance. Gaitonde et al., 1965) is rapidly converted into l*C-labelled glutamate and associated amino acids, it was of interest to investigate whether a part of the labelled amino acids was formed subsequent to the direct oxidation of [ U-'*C]glucose by the hexose monophosphate pathway. It was decided, therefore, to block the hexose monophosphate pathway by inhibiting the activity of 6-phosphogluconate dehydrogenase by injecting 6-aminonicotinamide to rats. 6-Aminonicotinamide is incorporated into NADP and NAD giving 6-aminonicotinamide analogues of these cofactors, i.e. 6-aminonicotinamide-adenine dinucleotide phosphate and 6-aminonicotinamid*adenine dinucleotide respectively, which are strong competitive inhibitors of the enzymes utilizing the natural cofactors. In the brain the main biochemical observation is a severalfold increase of 6-phosphogluconate, indicating almost complete inhibition of 6-phosphogluconate dehydrogenase (Herken Br Lange, 1969) . Animals treated with 6-aminonicotinamide show a variety of neurological abnormalities, e.g. irreversible paralysis, impaired righting responses, unsteadiness of gait, anorexia and blindness. In 2 days the animals show lesions in the central nervous system (spinal cord and brain) confined to the grey matter, sparing the white matter and peripheral nerves (Wolf et al., 1959) .
At 30 min after administration of [U-14Clglucose to rats paralysed in 4 h after an injection of 6-aminonicotinamide the ' *C content of brain amino acids decreased by 16% (P< 0.001). This decrease was reflected in glutamate and associated amino acids. The pool sizes of glutamate and 4-aminobutyrate decreased (P = 0.01), glucose increased (P< 0.01), lactate slightly decreased (P < 0.05) in the brain of the treated rats. The specific radioactivities of brain glucose and lactate m the treated group were similar to those in the control group (five animals in each group). The I4C content of brain 6-phosphogluconate was significantly higher in the treated group; this indicated that the hexose monophosphate shunt pathway was blocked or strongly inhibited. The results are interpreted as evidence that the triose phosphate formed in the adult brain by the hexose monophosphate pathway and subsequently glycolysed contributes to a measurable extent to the labelling (or formation) of glutamate and 4-aminobutyrate. Thus the inhibition of the hexose monophosphate shunt pathway in certain (neuronal) brain cells might be responsible for the disturbance in the normal functioning of the brain.
